Search
for
Sort by
Research 391–420 of 1000+
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Identification of potential key genes and pathways associated with the Pashmina fiber initiation using RNA-Seq and integrated bioinformatics analysis
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Emerging drugs for alopecia areata: JAK inhibitors
- Excellent response to tofacitinib treatment in a patient with alopecia universalis
- Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles
- Rethinking the classification of alopecia areata
- Janus Kinase Inhibitors for Alopecia Areata
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Unraveling the secret life of the hair follicle: from fungi to innovative hair loss therapies
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- Acne exacerbation after tofacitinib treatment for alopecia areata
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources